Click here to view all current course offerings by The Academy at BioNJ.
Rutgers University is pleased to offer the following courses through The Academy at BioNJ:
Digital Marketing for the Life Sciences Industry
Marketing transcends all types of business interactions, regardless of industry or type of company. In the life sciences and pharmaceutical industries, regulatory considerations can affect the ways in which you employ digital marketing tools and channels. At a time when digital has revolutionized marketing in myriad ways, many have been left to navigate a new environment and transform their strategies in the face of expanding media channels and platforms, as well as new rules of engagement with today’s highly informed consumers.
Through this class, participants learn about the new and emerging marketing technologies available to them. They will be empowered with an actionable digital marketing framework through which to evaluate, plan and execute digital strategies and initiatives.
Digital Marketing for the Life Sciences industry is a fast-paced, interactive primer designed for:
Brand or product managers
Legal and IT professionals
Anybody who a direct or indirect role in marketing products in the life sciences vertical
Click here to return to top of page.
How to Create and Lead High-Performing Teams
Today’s leaders are taught enough management basics to run their teams but not enough leadership skills to create truly high performing teams. In order to turn a group of employees into a high performing team, the leader must master situational leadership, motivational and engagement techniques, and delegation for true success. The leader needs to be equally in tune with the many needs of its team as a unit as well as the individuals to improve productivity and create sustainable and successful teams.
Key Topics Include:
- Situational Leadership – Assessment, Analysis, and Application
- Balancing the needs of the team and the needs of the individuals
- Engagement and motivation as success factors on the team
- Effective delegation as a driver of team performance
- Meet the many needs of your team and its individuals in a variety of leadership situations for enhanced organizational effectiveness
- Motivate your staff given their experience level to enhance discretionary effort
- Engage your staff with the proper balance of challenge and competence to improve their productivity
- Delegate correctly to each member of your team based on their readiness for the task to improve personal and team efficiency
Who Should Attend:
This program is designed for team managers, directors and executives who are responsible for leading teams to produce transformative outcomes and increase departmental or organizational efficiency and ROI.
Click here to return to top of page.
Navigating the Complexities of US Healthcare Program Series
The healthcare industry in the United States is one of the most controversial and changing systems in the global economy. In recent years, it has transformed into a conglomerate of public and private entities, non-profit and for-profit organizations, each with their own agendas and funding systems.
In order to sustain effective and efficient operations, it is critical for management to understand the importance of structure and administration in the healthcare landscape. This program series takes an inside look at the organizational and functional aspects of the healthcare industry as a result of public and private influences, managed care, the free market, regulation, the pharmaceutical industry, patients and consumers. It will focus on developing an understanding of the evolving U.S. healthcare environment and the role of the bio/pharmaceutical industry.
Program series topics include:
- The nature and characteristics of the healthcare system
- Public / private sector roles
- Healthcare markets and competition
- The impact of managed care and insurance
- Congressional proposals and regulatory characteristics
- Health policy
- Healthcare reform strategies
- The role of patients and consumers
Workshop Series Descriptions:
(Each workshop may be taken individually or the series completed for a Rutgers program certificate)
The Essentials of Managed Care (full day)
The program will provide organizations with a clear understanding of the complexities that exist in positioning pharmaceuticals and biopharmaceuticals in the current U.S. health care system. Based on the concept of creating a patient journey through the managed markets landscape, this customized training will provide the organization with a thorough understanding of this industry’s rapid evolution driven by both public and private influences.
Upon completion of the program, each participant will:
- Have a thorough understanding of rapidly changing healthcare environment concepts and trends
- Understand the impact of benefit design and formulary management on your business
- Be able to incorporate key managed markets opportunities and concepts into the management and delivery of drugs
- Obtain a working knowledge of the “5th” P that is focused on the payer and their business models
- Be able to articulate the monetary aspects of “Follow the Dollar” in today’s managed care environment
Covered America (half day)
This program explores America’s healthcare spending crisis, the Affordable Care Act’s efforts to expand access while lowering costs and improving quality, and the types of healthcare coverage available to Americans. These include Medicare, Medicaid, state health insurance exchanges, and commercial insurers.
- Understand how healthcare in the U.S. is delivered
- Differentiate between the public and private sector and who gets what coverage
- Define how healthcare is paid for with a description of the types of medical and pharmacy benefits
Market Access: Demonstrating Value (half day)
As payer and provider customers look to reduce costs and increase quality, demonstrating value is becoming increasingly important for pharmaceutical manufacturers to obtain favorable access for their branded drugs. This presentation explores the effectiveness of pricing strategy, prescription drug reimbursement, and contracting principles in the evolving healthcare market. Through interactive discussion and hands on workshops, participants will explore opportunities to adopt innovative approaches in response to marketplace opportunities.
- Define market access and what it means in the public and private sectors
- Build an understanding on how and why bio/pharma contracts with payers
- Discuss innovative approaches to market access that can begin to reshape the value of bio/pharma brands
Evolution of Healthcare Providers: The Trend Toward Organized Providers (half day)
This program explores the trends that are causing many physicians to abandon their small, private practices in favor of larger medical groups, health systems, and organized providers such as ACOs, IDNs, and PCMHs. Trends include the focus on quality, the implementation of electronic health records, healthcare cost drivers, the Affordable Care Act, and marketplace evolution, among others.
- Define organized providers and demonstrate the trends that pushed providers to join
- Understand implications of the drivers to improve quality and lower costs that are a reflection of the changing reimbursement models away from Fee For Service
- Describe what the changing role of bio/pharma is to become more engaged in these emerging business models
Local Dynamics in Healthcare Biopharma (half day)
As the healthcare marketplace evolves, the traditional pharmaceutical sales approach of “reach and frequency” will be impacted in some territories. In the coming years, it will be important for pharmaceutical manufacturers to understand payer and provider dominance and develop a targeted approach that responds to the trends in each geography.
- Define how bio/pharma companies can redefine their approach to the U.S. market; think nationally and act locally
- Describe what drivers impact each market giving them a market personality
- Learn how to apply market insights to define local market approaches through segmentation of like markets
Emerging from Disruption (half day)
The Affordable Care Act dramatically affects our industry and the pharmaceutical company’s ability to adapt to the changing environment. It will determine the future course and relevance for the coming years. This presentation helps clients make sense of the evolving marketplace dynamics and develop strategies to enhance their success. The goal of this program is to generate thinking by your team to identify the best course of action to maximize opportunities in the “new” healthcare market.
- PPACA has resulted in many changes that will span ten years – determine which components have a profound impact on the bio/pharmaceutical industry
- Describe how the changes are affecting the decision processes of the healthcare stakeholders
- Demonstrate how bio/pharma companies are responding
Integrating Market Drivers into Strategy (half day)
In order to keep up with the constant change that takes place in healthcare, leaders in the pharmaceutical industry need to develop strategies that address current market drivers and prepare for an uncertain future. Strategically addressing specific market drivers will improve biopharma innovation. This presentation explores the critical aspects of the Affordable Care Act to which pharma must respond, including the impact of the legislation on the pharmaceutical industry and our payer and provider customers, including commercial managed care organizations, Medicare, Medicaid, and Accountable Care Organizations, among others. Through interactive dialogue and collaboration with their peers, participants will identify opportunities to generate innovative solutions to customers’ unmet needs.
- Learn to build on the foundation of strategy
- Develop an understanding of strategy as a process
- Create a template that supports strategy development and alignment of tactics
Click here to return to top of page.
Supply Chain Marketing for the Life Sciences Industry
Supply Chain Management is a business integrating process used to create and sustain competitive advantage based on the delivery to customers of basic (expected) and value-added (unexpected) services. This special, one day program explores key theories and models of supply chain, and applies them to the specialized world of the life sciences industry. Through this course, you will learn to make No/No Go decisions, evaluation a drug’s suitability for manufacturing, and special industry considerations related to production, storage and disposal of biologics.
Supply Chain Development for the Life Sciences Industry is for employees and leaders who are directly or indirectly engaged with supply chain issues. Whether you are on the sourcing or utilization side of the supply chain, if you need a firm understanding of how and why supply chain development is evolving, and how to make the best decisions possible, this program is for you.
Click here to return to top of page.